- All sections
- A - Human necessities
- A61P - Specific therapeutic activity of chemical compounds or medicinal preparations
- A61P 1/06 - Anti-spasmodics, e.g. drugs for colics, esophagic dyskinesia
Patent holdings for IPC class A61P 1/06
Total number of patents in this class: 229
10-year publication summary
|
5
|
22
|
15
|
15
|
29
|
23
|
25
|
15
|
9
|
7
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Thetis Pharmaceuticals LLC | 23 |
6 |
| Société des Produits Nestlé S.A. | 10107 |
5 |
| Ltd "valenta-intellekt" | 155 |
5 |
| Cinclus Pharma Holding AB | 35 |
5 |
| Nxera Pharma UK Limited | 188 |
4 |
| Janssen Pharmaceutica N.V. | 3171 |
3 |
| Allergan, Inc. | 2169 |
3 |
| BGI Shenzhen Co., Limited | 290 |
3 |
| BioGaia AB | 203 |
3 |
| enGene, Inc. | 39 |
3 |
| Heptares Therapeutics Limited | 73 |
3 |
| Nippon Chemiphar Co., Ltd. | 226 |
3 |
| Chain Biotechnology Limited | 10 |
3 |
| The Johns Hopkins University | 5875 |
2 |
| Amino Up Chemical Co., Ltd. | 18 |
2 |
| Astellas Pharma Inc. | 1043 |
2 |
| Centre hospitalier universitaire de Toulouse | 181 |
2 |
| Children's Medical Center Corporation | 1956 |
2 |
| Genome Research Limited | 103 |
2 |
| Instituto Nacional de Tecnologia Agropecuaria (INTA) | 9 |
2 |
| Other owners | 166 |